Study of gold nanoparticles for mammography diagnostic and radiotherapy improvements
Status PubMed-not-MEDLINE Language English Country Poland Media print-electronic
Document type Journal Article
PubMed
31388339
PubMed Central
PMC6675973
DOI
10.1016/j.rpor.2019.07.005
PII: S1507-1367(19)30055-0
Knihovny.cz E-resources
- Keywords
- Diagnostics, Gold nanoparticles, Mammography, Radiotherapy,
- Publication type
- Journal Article MeSH
AIM: A study on the possibility to use gold nanoparticles in mammography, both for a better image diagnostics and radiotherapy, is presented and discussed. We evaluate quantitatively the increment of dose released to the tumor enriched with Au-NPs with respect to the near healthy tissues, finding that for X-rays the increase can reach two orders of greater intensity. BACKGROUND: Gold nanoparticles continue to be investigated for their potential to improve existing therapies and to develop novel therapies. They are simple to obtain, can be functionalized with different chemical approaches, are stable, non-toxic, non-immunogenic and have high permeability and retention effects in the tumor cells. The possibility to use these for breast calcified tumors to be better treated by radiotherapy is presented as a possible method to destroy the tumor. MATERIALS AND METHODS: The nanoparticles can be generated in water using the top-down method, should have a size of the order of 10-20 nm and be treated to avoid their coalescence. Under diagnostic X-ray monitoring, the solution containing nanoparticles can be injected locally inside the tumor site avoiding injection in healthy tissues. The concentrations that can be used should be of the order of 10 mg/ml or higher. RESULTS: An enhancement of the computerized tomography diagnostics using 80-150 keV energy is expected, due to the higher mass X-ray coefficient attenuation with respect to other contrast media. Due to the increment of the effective atomic number of the biological tissue containing the gold nanoparticles, also an improvement of the radiotherapy effect using about 30 keV X-ray energy is expected, due to the higher photoelectric cross sections involved. CONCLUSIONS: The study carried out represents a feasibility proposal for the use of Au-nanoparticles for mammographic molecular imaging aimed at radiotherapy of tumor nodules but no clinical results are presented.
See more in PubMed
Restuccia N., Torrisi L. Nanoparticles in liquids generated laser as contrast medium and radiotherapy intensifiers. EPJ Web Conf. 2018;167:04007.
Turner J.E. Wiley Interscience Publication; New York: 1995. Atoms, Radiation, and Radiation protection, II Edition. ISBN: 0471-59581-0. http://www.nuclear.dababneh.com/Radiation-Undergrad-2/Atoms,%20Radiation,%20and%20Radiation%20Protection.pdf.
Murty R.C. Effective atomic numbers of heterogeneous materials. Nature. 1965;207:398–399.
Tiwari P.M., Vig K., Dennis V.A., Singh S.R. Functionalized gold nanoparticles and their biomedical applications. Nanomaterials (Basel) 2011;1(1):31–63. PubMed PMC
Torrisi L., Restuccia N., Cuzzocrea S., Paterniti I., Ielo I., Pergolizzi S., Cutroneo M., Kovacik L. Laser-produced Au nanoparticles as X-ray contrast agents for diagnostic imaging. Gold Bull. 2017;50(1):51–60.
Spadavecchia J., Movia D., Moore C. Targeted polyethylene glycol gold nanoparticles for the treatment of pancreatic cancer: from synthesis to proof-of-concept in vitro studies. Int J Nanomed. 2016;11:791–822. https://www.dovepress.com/targeted-polyethylene-glycol-gold-nanoparticles-for-the-treatment-of-p-peer-reviewed-article-IJN PubMed PMC
Torrisi L., Guglielmino S., Silipigni L. Study of gold nanoparticles transport by M13-phages towards disease tissues as targeting procedure for radiotherapy applications. Nano Res. 2018 (submitted for publication)
NIST, X-Ray Mass Attenuation Coefficients, actual website 2018: https://www.nist.gov/pml/x-ray-mass-attenuation-coefficients.
Ziegler J, SRIM, The Stopping and Range of Ions in the Matter, actual website 2018: http://www.srim.org/.
SREM, The Stopping and Range of Electrons in the Matter, actual website 2018: http://www.srim.org/SREM.htm.
Hidayat K., Chen G.C., Zhang R. Calcium intake and breast cancer risk: meta-analysis of prospective cohort studies. Br J Nutr. 2016;116(1):158–166. https://pdfs.semanticscholar.org/49af/9649debc7f28d0b75e6654daa6aa7cfc8b28.pdf PubMed
Beckett K.R., Moriarity A.K., Langer J.M. Safe use of contrast media: what the radiologist needs to know. Radiographics. 2015;35(6):1738–1750. https://www.ncbi.nlm.nih.gov/pubmed/26466182 PubMed
Gerweck L.E., Kozin S.V. Relative biological effectiveness of proton beams in clinical therapy. Radiother Oncol. 1999;50(2):135–142. https://www.ncbi.nlm.nih.gov/pubmed/10368035 PubMed
Thwaites D.I. Bragg's rule of stopping power additivity: a compilation and summary of results. Radiat Res. 1983;95(3):495–518. http://www.rrjournal.org/doi/abs/10.2307/3576096 DOI
Hickey J.W., Santos J.L., Williford J.M., Mao H.Q. Control of polymeric nanoparticle size to improve therapeutic delivery. J Control Release. 2015;219:536–547. PubMed PMC
Hainfeld J.F., Slatkin D.N., Smilowitz H.M. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol. 2004;49:N309–N315. http://iopscience.iop.org/article/10.1088/0031-9155/49/18/N03/meta PubMed DOI